Pregnancy Clinical Trial
Official title:
Pregnancy and Physical Activity: Text-message Referral to Evidence-based Websites
Verified date | February 2015 |
Source | Arizona State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Fewer pregnant women achieve recommendations for physical activity (PA) (30 minutes of
moderate PA 5 days of the week) as compared to non-pregnant women (15.8% to 26.1%
respectively), and PA participation declines as pregnancy progresses. The benefits of PA
during pregnancy are abundant to both the mother (e.g., reduced weight gain, lower risk of
gestational diabetes) and the fetus (e.g., decreased fat mass, improved stress tolerance).
Pregnancy represents a significant time in a woman's life in which she may be motivated to
change her health behaviors due to concerns for the healthy development of the fetus and a
quick return to pre-pregnancy weight. Hence, pregnancy represents a critical time to support
women in PA participation.
In our previous research, 94% of pregnant and postpartum women of varying socioeconomic
statuses reported using the Internet for pregnancy and PA information. Despite some women
increasing their PA participation as a result, most did not know if a website was reputable
or reliable (i.e. evidence-based). Studies have reported that most online health information
is unregulated and inaccurate. Further, women often receive inadequate PA information from
physicians who are constrained by time and lack of knowledge about PA. Therefore, directing
pregnant women to evidence-based websites via text messaging may provide a feasible approach
to improve PA participation. PA participation in pregnant women is an ongoing challenge that
warrants testing of innovative solutions.
The purpose of this study is to determine the feasibility of using mobile phone text
messaging to refer pregnant women to evidence-based websites for PA information to increase
PA levels.
Status | Completed |
Enrollment | 82 |
Est. completion date | April 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria (Phase 1): - physician, nurse/staff, or pregnant patient at one of the participating physician sites - able to speak English - willingness to participate in one 1-hour interview - 18 years of age or older. Inclusion Criteria (Part 2 of Phase 1) - pregnant or has been pregnant - able to speak English - willingness to participate in the 5 minute survey - 18 years of age or older. Inclusion Criteria (Phase 2) - 8-20 weeks gestation - 18 years of age or older - own a smartphone with text message capability - regular access to a computer - ability to speak/read/understand English - resident of the United States - willingness to provide the research team with cell phone number to receive text messages - not currently meeting physical activity guidelines of 30 minutes of moderate physical activity 5 days of the week. Exclusion Criteria: - pregnant women who are high risk as defined by the absolute and relative contraindications of exercise outlined in The American Congress of Obstetricians and Gynecologists' Position Statement on Exercise During the Pregnancy and Postpartum Period - women who have physical limitations to physical activity - women whose doctors instruct them NOT to be physically active during pregnancy and - women who are currently meeting the physical activity recommendations of 30 minutes of moderate physical activity 5 days of the week |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Arizona State University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Minutes Spent Doing Physical Activity Measured via a Physical Activity Monitor (FitBit) | 20 to 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |